The University Clinical Center Tuzla (UKC Tuzla) has implemented a new reverse osmosis system at the Clinic for Internal Diseases, Department of Nephrology, Hemodialysis, and Transplantation. Worth 280,000 KM (excluding VAT), the system was accompanied by the adaptation of the treatment space, significantly improving both technical and hygienic conditions for hemodialysis.
Reverse osmosis is an advanced water purification process that uses semi-permeable membranes to remove harmful microorganisms, salts, heavy metals, chemicals, and other impurities. Since water is a critical medium in dialysis treatment, its purity directly impacts the safety, quality, and effectiveness of the therapy.
The new system enhances microbiological and chemical safety, reduces the risk of infections, inflammation, and adverse reactions, and improves treatment tolerability and clinical outcomes. It also ensures stable and continuous operation while optimizing water and energy consumption.
“By implementing this new reverse osmosis system, we have taken an important step toward providing safer, more efficient, and higher-quality dialysis treatments for our patients. This investment significantly benefits those on the hemodialysis program by enhancing safety, reducing the risk of complications, and improving treatment tolerability and effectiveness. The introduction of this technology reflects our broader commitment to modernizing and improving equipment across all areas of UKC Tuzla,” said Prof. Dr. Šekib Umihanić, Director of UKC Tuzla.
